medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2007, Number 3

<< Back Next >>

Ann Hepatol 2007; 6 (3)

Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren’s syndrome

Montaño-Loza AJ, Crispín-Acuña JC, Remes-Troche JM, Uribe M

Language: English
References: 37
Page: 150-155
PDF size: 94.36 Kb.


ABSTRACT

Background/Aims: Patients with primary Sjögren’s syndrome may present liver involvement. Our goals were to establish the prevalence of abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren’s syndrome and correlate their presence with other clinical and laboratory features. Methods: Ninety-five patients with diagnosis of primary Sjögren’s syndrome were studied. Data on gender, age, clinical features, liver biochemistries, tests of inflammation and autoimmunity, and concomitant diseases were collected. Results: Forty-two patients (44%) had abnormal hepatic biochemistries, and of these 19 patients (20%) had clinical liver disease. Patients with abnormal hepatic biochemistries had higher frequency of autoimmune hypotiroidism, arthritis, vasculitis, Raynaud’s phenomenon, higher sedimentation rate, and higher frequency of antinuclear and antimitochondrial antibodies than patients with normal liver biochemistries (P ‹ 0.05 for each). Patients with clinical liver disease had higher frequency of arthritis, vasculitis, and higher frequency of antimitochondrial antibodies than patients without clinical liver disease (P ‹ 0.05 for each). Twenty-one patients had diagnosis of a specific liver disease, such as hepatitis C virus infection (n = 11), autoimmune hepatitis (n = 2), primary biliary cirrhosis (n = 5), nonalcoholic fatty liver disease (n = 2), and hepatitis B virus infection (n = 1). In half of patients with liver involvement a definitive cause could not be identified. Conclusion: Liver involvement is frequently found in patients with primary Sjögren’s syndrome, and its presence is associated with clinical features of systemic disease, and markers of autoimmunity and inflammation. There may be a subgroup of patients with liver involvement secondary to primary Sjögren’s syndrome.


REFERENCES

  1. Fox RI. Sjögren’s syndrome. Lancet 2005; 366: 321-31.

  2. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004; 63: 123-129.

  3. Whaley K, Goudie RB, Williamson J, Nuki G, Dick WC, Buchanan WW. Liver disease in Sjögren’s syndrome and rheumatoid arthritis. Lancet 1970; 1: 861-863.

  4. Skopuli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjögren’s syndrome. Br J Rheumatol 1994; 33: 745-748.

  5. Tsianos EB, Vasakos S, Drosos AA, Malamou-Mitsi VD, Moutsopoulos HM. The gastrointestinal involvement in primary Sjögren’s syndrome. Scand J Rheumatol 1986; 61: 151-155.

  6. Lindgren S, Manthorpe R, Eriksson S. Autoimmune liver disease in patients with primary Sjögren’s syndrome. J Hepatol 1994; 20: 354-58.

  7. Masaki N, Hayashi S. Autoimmune liver disease complicating Sjögren’s syndrome. Nippon Rinsho 1995; 53: 2530-35.

  8. Kaplan MJ, Ike RW. The liver is a common non-exocrine target in primary Sjögren’s syndrome: A retrospective review. BMC Gastroenterology 2002; 2: 21-30.

  9. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004; 97: 397-406.

  10. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.

  11. Hansen BU, Lindgren S, Eriksson S, Henricsson V, Larsson A, Mathorpe R, Warfulnge G. Clinical and immunological features of Sjögren’s syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med Scand 1988; 224: 611-19.

  12. Archimandritis A, Tjivras M, Tsirantonaki M, Hatzis G, Delladetsima I. Sjögren’s syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: a case of autoimmune cholangitis. J Clin Gastroenterol 1995; 20: 268-78.

  13. Alarcon-Segovia D, Diaz-Jouanen E, Fishbein E. Features of Sjögren’s syndrome in primary biliary cirrhosis. Ann Intern Med 1973; 79: 31-38.

  14. Matsumoto T, Morizane T, Aoki Y, Yamasaki S, Nakajima M, Enomoto N, Kobayashi S, et al. Autoimmune hepatitis in primary Sjögren’s syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjögren’s syndrome. Pathol Int 2005; 55: 70-6.

  15. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 515-20.

  16. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, et al. Lymphocytic sialadenitis of Sjögren’s syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-23.

  17. Pirisi M, Scott C, Fabris C, Ferraccioli G, Soardo G, Ricci R, Toniutto P, et al. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 1994; 29: 940-42.

  18. Scott CA, Avellini C, Desinan L, Pirisi M, Ferraccioli G, Bardus P, Fabris C, Casatta L, Bartoli E, Beltrami CA. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren’s syndrome. Histopathology 1997; 30: 41-48.

  19. Coll J, Gambus G, Corominas J, Tomas S, Esteban JI, Guardia J. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren’s syndrome with and without hepatitis C virus infection. Ann Rheum Dis 1997; 56: 390-92.

  20. Jorgensen C, Legouffe MC, Perney P. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39: 1166-71.

  21. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-48.

  22. Wattiaux MJ. Sindrome de Gougerot Sjögren et virus de l’hepatite C: quels liens? Presse Medicale 1997; 26: 652-57.

  23. Koike K, Moriya K, Ishibashi K, Yotsuyagani H, Shintani Y, Fujie H, Kurokawa K, et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997; 94: 233-36.

  24. Aprosin ZG, Serov VV, Lopatkina TN. The hepatitis B virus as a probable etiological factor in Sjögren’s disease. Ter Arkh 1993; 65: 73-78.

  25. Garcia-Carrasco, Ramos M, Cervera R, Font J, Vidal J, Munoz FJ, Miret C, et al. Hepatitis C virus infection in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56: 173-5.

  26. Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis and Sjögren’s syndrome: a syndrome complex. Am J Surg 1984; 147: 822-26.

  27. Gonzalez-Alvaro I, Carmona-Ortell L, Amigo-Etxenagusia A, Castaneda Sanz S. Nodular regenerative hyperplasia of the liver and primary Sjögren’s syndrome. J Rheumatol 1994; 21: 168-69.

  28. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, et al. Preliminary criteria for the classification of Sjögren’s syndrome. Arthr Rheum 1993; 36: 340-47.

  29. Vitali C, Bombardieri S. The diagnosis of Sjögren’s syndrome: definition and validation of classification criteria for this disorder. Ann Med Interne (Paris) 1998; 149: 12-16.

  30. Peene I, Meheus L, Veys E, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001; 60: 1131-1136.

  31. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996; 24: 1068-1073.

  32. Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986; 31: 705-11.

  33. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993; 105: 1522-1528.

  34. Roberts-Thompson PJ, Wernick RM, Ziff M. Quantitation of rheumatoid factor by laser nephelometry. Rheumatol Int 1982; 2: 17-20.

  35. Webb J, Whaley K, MacSween RN, Nuki G, Dick WC, Buchanan WW. Liver disease in rheumatoid arthritis and Sjögren’s syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis 1975; 34: 70-81.

  36. Golding PL, Bown A, Mason AMS, Taylor E. Sicca complex in liver disease. BMJ 1970; 4: 340-2.

  37. Vogel C, Wittenborg A Reichart P. Involvement of liver in Sjögren’s syndrome. Oral Surg 1980; 50: 26-9.




2020     |     www.medigraphic.com